MiMedx (MDXG) CCO receives shares from PSU vesting, with tax withholding

Rhea-AI Filing Summary

MIMEDX GROUP Chief Commercial Officer Kimberly Maersk-Moller reported compensation-related share activity. On this Form 4, 42,845 shares of common stock were acquired on March 10, 2026 through the vesting of performance stock units granted on March 13, 2023. Of these, 21,270 shares were withheld to cover tax obligations required by company policy, leaving her with 336,212 shares of common stock owned directly after the transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maersk-Moller Kimberly

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		42,845(1)	A	$4.5	357,482	D
Common Stock	03/10/2026		F		21,270(2)	D	$4.5	336,212	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13, 2023.

2. The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.

Remarks:

	/s/ William F. Hulse, as attorney-in-fact for Kimberly Maersk-Moller	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MDXG’s Kimberly Maersk-Moller report on this Form 4?

Kimberly Maersk-Moller reported the vesting of performance stock units, resulting in 42,845 MiMedx common shares being issued as compensation. A portion of these shares was simultaneously withheld to satisfy tax obligations required under company policy.

How many MiMedx (MDXG) shares vested for the CCO in this filing?

The filing shows 42,845 shares of MiMedx common stock issued to the Chief Commercial Officer upon vesting of performance stock units. These units related to a performance period running from January 1, 2023 to December 31, 2025 and were granted on March 13, 2023.

Were any MDXG shares sold on the open market in this Form 4?

No open-market sale was reported. The 21,270 shares shown as a disposition were withheld by the company to pay tax liabilities triggered by the performance stock unit vesting, consistent with company policy, rather than being sold in a discretionary market transaction.

How many MiMedx (MDXG) shares does Kimberly Maersk-Moller own after these transactions?

After the reported compensation-related transactions, Kimberly Maersk-Moller directly owns 336,212 shares of MiMedx common stock. This total reflects the newly vested shares net of the portion withheld to cover tax obligations associated with the vesting event.

What is the nature of the tax-related disposition in this MDXG Form 4?

The Form 4 shows 21,270 shares disposed of under code F, meaning they were withheld to pay tax liabilities arising from the vesting of performance stock units. This is a non-market, administrative transaction rather than a voluntary sale of shares.

What performance period did the vested MiMedx (MDXG) PSUs cover?

The vested performance stock units covered a performance period from January 1, 2023 to December 31, 2025. They were originally granted on March 13, 2023, and the resulting share payout was reported with a transaction date of March 10, 2026.